"I am still negative": Female sex workers' perspectives on uptake and use of daily pre-exposure prophylaxis for HIV prevention in South Africa

PLoS One. 2019 Apr 9;14(4):e0212271. doi: 10.1371/journal.pone.0212271. eCollection 2019.

Abstract

Women remain highly vulnerable to HIV infection in sub-Saharan Africa, with female sex workers (FSWs) facing some of the highest rates of HIV. Oral pre-exposure prophylaxis (PrEP) has the potential to reduce new infections among populations at highest risk and end-user perspectives of actual use in 'real-world' settings are critical to informing PrEP implementation. This paper presents findings from serial in-depth interviews (IDIs) conducted with FSW participants during the course of the Treatment And Prevention for Sex workers (TAPS) Demonstration Project in South Africa, exploring the lived experiences and perceptions of taking up and using PrEP. This research provides insight into risks and responsibilities facing FSWs perceived as prominent drivers in taking up and using PrEP, how PrEP was adopted to mitigate risk or ameliorate realities, and the characteristics of PrEP most valued, all of which are critical to consider in scale-up. Overall, distrust in the existence and/or efficacy of PrEP affected the motivation of women to come to the clinic and to maintain use. As one of the first reports of PrEP use among FSWs outside of a clinical trial setting, this research shows that it will be important to ensure accurate, relevant, and widespread messaging in communities to generate demand and support for PrEP.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adult
  • Anti-HIV Agents / administration & dosage*
  • Female
  • HIV / drug effects
  • HIV / pathogenicity
  • HIV Infections / epidemiology
  • HIV Infections / prevention & control*
  • HIV Infections / virology
  • Humans
  • Male
  • Patient Acceptance of Health Care
  • Pre-Exposure Prophylaxis*
  • Safe Sex
  • Sex Workers*
  • South Africa / epidemiology

Substances

  • Anti-HIV Agents

Grants and funding

HR and RE received grant #OPP1084416 from the Bill and Melinda Gates Foundation to support this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.